ExploreWatchlistsPricing
  1. JP-listed companies
  2. Eisai Co., Ltd.
  3. Financials
  4. Gross margin (%)

Eisai Co., Ltd. (4523)

Market cap
¥1.16T
P/E ratio
21.5x
Eisai develops, manufactures and sells prescription drugs and over-the-counter medicines globally across Japan, North America, China, Europe and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202676.8-2.27%
Mar 31, 202578.6-0.56%
Mar 31, 202479.1+3.87%
Mar 31, 202376.1-1.00%
Mar 31, 202276.9+2.47%
Mar 31, 202175+0.38%
Mar 31, 202074.7+4.83%
Mar 31, 201971.3+84.65%
Mar 31, 201838.6+13.50%
Mar 31, 201734-12.90%
Mar 31, 201639.1+3.26%
Mar 31, 201537.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat